These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35243952)

  • 21. An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record.
    Schuler KP; Hemnes AR; Annis J; Farber-Eger E; Lowery BD; Halliday SJ; Brittain EL
    Respir Res; 2022 May; 23(1):138. PubMed ID: 35643554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Machine Learning Approach to Identify Predictors of Severe COVID-19 Outcome in Patients With Rheumatoid Arthritis.
    Burns SM; Woodworth TS; Icten Z; Honda T; Manjourides J
    Pain Physician; 2022 Nov; 25(8):593-602. PubMed ID: 36375193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD).
    Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Liu S; Cloutier M; Lefebvre P
    Pulm Circ; 2023 Apr; 13(2):e12218. PubMed ID: 37051491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database.
    Burger CD; Pruett JA; Lickert CA; Berger A; Murphy B; Drake W
    J Manag Care Spec Pharm; 2018 Mar; 24(3):291-302. PubMed ID: 29406840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a pulmonary arterial hypertension (PAH) patient cohort and study of its burden of illness in Programme de Médicalisation des Systèmes d'information (PMSI).
    Exposto F; Petrică N; Davies E; Beaudet A
    Int J Cardiol; 2020 May; 306():175-180. PubMed ID: 32113663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.
    Exposto F; Hermans R; Nordgren Å; Taylor L; Sikander Rehman S; Ogley R; Davies E; Yesufu-Udechuku A; Beaudet A
    Ther Adv Respir Dis; 2021; 15():1753466621995040. PubMed ID: 33620026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms.
    Mathai SC; Hemnes AR; Manaker S; Anguiano RH; Dean BB; Saundankar V; Classi P; Nelsen AC; Gordon K; Ventetuolo CE
    Ann Am Thorac Soc; 2019 Jul; 16(7):797-806. PubMed ID: 30865835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pulmonary hypertension gas exchange severity (PH-GXS) score to assist with the assessment and monitoring of pulmonary arterial hypertension.
    Woods PR; Taylor BJ; Frantz RP; Johnson BD
    Am J Cardiol; 2012 Apr; 109(7):1066-72. PubMed ID: 22245407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients.
    Sikirica M; Iorga SR; Bancroft T; Potash J
    BMC Health Serv Res; 2014 Dec; 14():676. PubMed ID: 25539602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension.
    Haarman MG; Lévy M; Roofthooft MTR; Douwes JM; Vissia-Kazemier TR; Szezepanski I; Berger RMF; Bonnet D
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32855224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension: An analysis of the TOPP registry.
    Beghetti M; Brand M; Berger RMF; Humpl T; Wheeler JG; Ivy DD; Bonnet D;
    Int J Cardiol; 2019 Aug; 289():110-115. PubMed ID: 31072635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Takaya Y; Akagi T; Sakamoto I; Kanazawa H; Nakazawa G; Murakami T; Yao A; Nanasato M; Saji M; Hirokami M; Fuku Y; Hosokawa S; Tada N; Matsumoto K; Imai M; Nakagawa K; Ito H
    Heart; 2022 Mar; 108(5):382-387. PubMed ID: 34415851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data.
    Gillmeyer KR; Nunez ER; Rinne ST; Qian SX; Klings ES; Wiener RS
    Chest; 2021 May; 159(5):1986-1994. PubMed ID: 33345949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Hay BR; Pugh ME; Robbins IM; Hemnes AR
    Chest; 2016 Mar; 149(3):660-6. PubMed ID: 26378379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
    Colalillo A; Grimaldi MC; Vaiarello V; Pellicano C; Leodori G; Gigante A; Romaniello A; Rosato E
    Rheumatology (Oxford); 2022 May; 61(6):2450-2456. PubMed ID: 34605890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension.
    Huang WC; Hsu CH; Sung SH; Ho WJ; Chu CY; Chang CP; Chiu YW; Wu CH; Chang WT; Lin L; Lin SL; Cheng CC; Wu YJ; Wu SH; Hsieh TY; Hsu HH; Fu M; Dai ZK; Kuo PH; Hwang JJ; Cheng SM;
    J Formos Med Assoc; 2019 Dec; 118(12):1584-1609. PubMed ID: 30926248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
    Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
    Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.